Filter
1352
Filtered Results: 1352
Text search:
biological
agents
Featured
Recommendations
144
New Publications
318
Language
Document type
No document type
720
Guidelines
244
Studies & Reports
216
Manuals
91
Strategic & Response Plan
33
Training Material
18
Fact sheets
17
Brochures
3
Situation Updates
3
Resource Platforms
2
Infographics
2
Online Courses
2
Dashboards/Maps
1
Countries / Regions
India
81
Global
58
Kenya
39
Nigeria
31
Sierra Leone
29
South Africa
25
Ethiopia
25
Africa
24
Western and Central Europe
21
Liberia
21
Tanzania
19
Uganda
19
Latin America and the Carribbean
18
Nepal
16
Bangladesh
14
Ghana
13
Philippines
13
Rwanda
11
Syria
11
Zimbabwe
10
Congo, Democratic Republic of
10
Zambia
10
Malawi
9
USA
9
South–East Asia Region
9
West and Central Africa
8
Eastern Europe
8
Brazil
8
Namibia
8
Ukraine
7
Mozambique
7
Cambodia
7
Germany
7
Lesotho
6
Guinea
6
Myanmar / Burma
6
Albania
5
Burkina Faso
5
Tajikistan
4
East and Southern Africa
4
South Sudan
4
Senegal
3
Eastern Europe and Central Asia
3
Paraguay
3
Spain
3
Vietnam
3
Mali
3
Angola
3
Eswatini/ Swaziland
3
Timor Leste/ East Timor
2
Thailand
2
China
2
Peru
2
Haiti
2
Guinea-Bissau
2
Venezuela
2
Lebanon
2
Sri Lanka
2
Libya
2
Botswana
2
Indonesia
2
Iraq
2
Pakistan
2
North Macedonia
1
Turkey
1
Cameroon
1
Iran
1
Singapore
1
Laos
1
Estonia
1
Niger
1
Mongolia
1
Asia
1
Middle East and North Africa
1
Western Pacific Region
1
Turkmenistan
1
Denmark
1
France
1
United Kingdom
1
Portugal
1
Latvia
1
Côte d’Ivoire / Ivory Coast
1
Argentina
1
Papua New Guinea
1
Moldova
1
Russia
1
Romania
1
Palestine
1
Authors & Publishers
Publication Years
Category
Countries
426
Clinical Guidelines
144
Key Resources
93
Public Health
88
Pharmacy & Technologies
49
Women & Child Health
40
Capacity Building
22
Toolboxes
Planetary Health
93
Rapid Response
85
COVID-19
83
Mental Health
78
TB
72
HIV
70
AMR
69
NTDs
66
Ebola & Marburg
56
Pharmacy
54
Specific Hazards
43
Conflict
26
Caregiver
25
NCDs
25
Global Health Education
21
Natural Hazards
16
Refugee
14
Zika
14
Disability
11
Cholera
7
Polio
7
Social Ethics
4
Health Financing Toolbox
3
South Sudan
1
The growing understanding of how sequence information can contribute to improved public health is driving global investments in sequencing facilities and programmes. The falling cost and complexity of generating GSD provides opportunities for expanding sequencing capacity; however, challenges to wid...
Each year since 2007, G-FINDER has provided policy-makers, donors, researchers and industry with a comprehensive analysis of global investment into research and development of new products to
prevent, diagnose, control or cure neglected diseases in low- and middle-income countries, making it the go...
Technology landscape
Accessed Febr. 6, 2020
The reader acknowledges that this report is intended as an evidence-based asthma management strategy, for the use of health professionals and policy-makers. It is based, to the best of our knowledge, on current best evidence and medical knowledge and practice at the date of publication. When assessi...
Drugs, Diagnostics, Vaccines, Preventive Technologies, Research toward a cure, and immune-based and gene therapies in development
orientaciones provisionales, 23 de abril de 2020
The report presents current information (updated to September 2015) on candidate vaccines, therapies and medical devices for Ebola and gives an overview of completed and on-going trials.
Asthma is the commonest chronic childhood disease and encompasses a spectrum of airway diseases with similar symptoms. Inaccurate diagnosis remains common, especially in younger children, with failure to characterize the different “asthmas.” Children worldwide repeatedly suffer symptoms which se...
The document "Chronic Respiratory Diseases: A Handbook for Pharmacists" outlines the significant role pharmacists play in managing asthma and COPD, emphasizing patient education, disease prevention, medication management, and promoting healthy lifestyles. It highlights the importance of pharmacists ...
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
Melarsoprol resistance represents the only example of widespread drug resistance in HAT patients wher...
Topics in Antiviral Medicine 25 Issue 2 May/June 2017
The reader acknowledges that this report is intended as an evidence-based asthma management strategy, for the use of health professionals and policy-makers. It is based, to the best of our knowledge, on current best evidence and medical knowledge and practice at the date of publication. When assessi...
El presente decálogo expone de manera concisa los aspectos esenciales de la enfermedad y recoge 10 puntos básicos, esquemáticos y orientados a la práctica para la atención pediátrica de la enfermedad de Chagas.
Elaborat în cadrul proiectului „Fortificarea controlului tuberculozei în Moldova”, finanţat de către
Fondul Global de combatere a SIDA, Tuberculozei şi Malariei.
En enero de 2020, el agente etiológico responsable de un grupo de casos de neumonía grave en Wuhan, China, fue identificado como un nuevo betacoronavirus (2019-nCoV), distinto del SARS-CoV y MERS-CoV (1) (2) (3). La secuencia genómica completa de este nuevo agente está disponible y se han desarr...
The WHO Guide on Oral Cholera Vaccines in Mass Immunization Campaigns provides guidance on the planning and implementation of oral cholera vaccine (OCV) campaigns. It covers key aspects such as when and where to use OCVs, vaccine specifications, and recommendations for use in endemic areas, outbreak...
